Pacific Biosciences of California (PACB) Stock
Pacific Biosciences of California (PACB) closed at $1.96 on Nov 13, 2026; its Tenet Score is 40 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $1.96
- Nov 13, 2026
- Market cap
- $613.3M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 1.07 – 3.44
- low → high
- Tenet Score
- 40/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. scores 40/100. Weak. Quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 40 is built from 3 of 4 pillars, from 45% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Value omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ~ Drawdown Context
- ✕ Reversal Evidence
Pays no dividend. Every dollar of profit is reinvested into the business.
13F flows & insider trades land here.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable p…
Common questions
What sector and industry is Pacific Biosciences of California in?
Pacific Biosciences of California is in the Healthcare sector and the Drugs industry.
What is Pacific Biosciences of California's Tenet Score?
Pacific Biosciences of California's Tenet Score is 40 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




